Recorded assignments recently made public by the USPTO reveal batches of US patents, one generally related to multi-display devices and another to drug delivery devices, on the move, to entities tied to experienced monetization teams—teams that have apparently secured the backing of the same prominent litigation funder. One of those entities is already in litigation, over previously received patents from the same source, while the other appears headed in that direction.